Neuropathology and amyloid-beta spectrum in a Bapineuzumab immunotherapy recipient
Manuscript Number:
10-1809R1
Author(s):
Thomas G. Beach, Ian D. Daugs, Jesse M. Hunter, Tyler A. Kokjohn, Chera L. Maarouf, Alex E. Roher, Marwan N. Sabbagh
Disclosures
Thomas G. Beach
Grants
Agency:
Avid Radiopharmaceuticals
Dates:
2009-present
Agency:
Bayer Healthcare
Dates:
2010-present
Agency:
GE Healthcare
Dates:
2010-present
Ian D. Daugs
Nothing to Disclose
Jesse M. Hunter
Nothing to Disclose
Tyler A. Kokjohn
Nothing to Disclose
Chera L. Maarouf
Nothing to Disclose
Alex E. Roher
Nothing to Disclose
Marwan N. Sabbagh
Consulting Fees:
MNS receives grant support (clinical trials) from BMS, Avid, GE, Bayer, Baxter, Wyeth, Janssen, Lilly and Medivation. MNS is also on the Consultant/advisory board for Janssen/Pfizer, Amerisciences, Eisai, Takeda and GSK, and